Skip to the page

Data / Form D filings / Lazzaro Medical, Inc.

Lazzaro Medical, Inc.: Form D filing

Lazzaro Medical, Inc., a biotechnology company in Boulder, CO, filed a Form D with the SEC in 2024. The latest, on July 22, 2024, reports $4.9 million sold of a $7.5 million offering to 14 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
1215 SPRUCE STREET, Boulder, CO, 80302
Phone
(866) 672-2800
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2019
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2014886

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jul 22, 2024New notice$7,520,000$4,920,000$2,600,00014Feb 9, 2022sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Robert A. IsraelDirector, Executive Officer, Promoter
Richard S. Lazzaro, M.D.Director, Executive Officer, Promoter
D. Dawn BitzExecutive Officer
Robert J. WiesenbergExecutive Officer
Ryan G. RedfordExecutive Officer
Frederick J. OnoratoExecutive Officer
James R. PolsenExecutive Officer

Other biotechnology companies in Colorado that filed recently

Every Form D from the week of Jul 22, 2024 · All recent filings in Colorado · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Lazzaro Medical, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.